Career Enhancement Program

职业提升计划概要/摘要 职业提升计划（CEP）的中心目标是利用MD安德森的资源， 杰出的年轻研究者，他们将通过以下措施降低卵巢癌的发病率和死亡率： 在该病的早期发现、预防和治疗方面取得进展。为了实现这一目标， SPORE CEP将提供两个奖项，每个奖项每年5万美元，为期两年，由SPORE资助， 从MD安德森那里拿到了相应的资金每个CEP奖的目的是准备选定的科学家， 成为卵巢癌相关学术研究的国际领导者。我们将通过以下方式实现这一目标： 积极招募最有前途的年轻研究人员，并建立个性化的 与临床和实验室导师和指导委员会一起制定发展计划，正式的课程工作， 指导赠款和论文写作，领导能力培训，参加国家会议，与 卵巢癌学者和完成和出版翻译卵巢癌研究计划。 在我们过去的SPORE奖项中，CEP已经发展了21名年轻调查员的职业生涯。第一年 在原批拨款中，三名博士后学员获得CE奖，18名教师获得资助， 自2000年以来，所有人都继续从事学术研究，13人主要从事卵巢癌研究 research.其中10人获得了同行评审的资助，另外两名获奖者获得了竞争性资助。 基金会赠款。最近资助周期的六名获奖者获得了一项R 01、一项R 03、两项CPRIT 奖项，两个得克萨斯州纳米技术中心赠款，一个利兹蒂尔克学者奖从卵巢 癌症研究基金和一个苏珊Poorman布莱基卵巢癌赠款。进入程序后， 获奖者发表了500多篇关于卵巢癌的同行评审论文。在所有获奖者中， 五个是当前SPORE的项目领导者、共同研究者、合作者或核心领导者（Anil Sood博士， Jinsong Liu，KK Wong，Vikas Kundra，and Guang Peng）.展望未来，CEP将由Anil Sood博士领导， 他是一个杰出的榜样和最有效的导师。

Career Enhancement Program SUMMARY/ABSTRACT The central goal of the Career Enhancement Program (CEP) is to use the resources at MD Anderson to train exceptional young investigators who will reduce the morbidity and mortality from ovarian cancer through making advances in the early detection, prevention, and treatment of this disease. To achieve this goal, the SPORE CEP will provide two awards, each of $50,000 annually for two years, funded from the SPORE and matching funds from MD Anderson. The intent of each CEP award is to prepare the selected scientists to become international leaders in academic research relevant to ovarian cancer. We will achieve this by aggressive recruitment of the most promising young investigators and the institution of an individualized development plan with clinical and a laboratory mentors and a mentoring committee, formal course work, coaching in grant and paper writing, leadership training, attendance at national meetings, networking with ovarian cancer scholars and completing and publishing a translational ovarian cancer research program. During our past SPORE awards, the CEP has developed the careers of 21 young investigators. In the first year of the original grant, three postdoctoral trainees received CE awards, and of the 18 faculty members supported since 2000, all have remained in academic research and 13 are engaged predominantly in ovarian cancer research. Ten have achieved peer-reviewed funding and two additional awardees have received competitive foundation grants. The six awardees in the most recently funded cycle received one R01, one R03, two CPRIT awards, two Texas Center for Nanotechnology Grants, one Liz Tilberis Scholar Award from the Ovarian Cancer Research Fund and one Susan Poorman Blackie Ovarian Cancer grant. After entering the program, awardees have published over 500 peer-reviewed papers regarding ovarian cancer. Of the faculty awardees, five are project leaders, co-investigators, collaborators or core leaders on the current SPORE (Drs. Anil Sood, Jinsong Liu, KK Wong, Vikas Kundra, and Guang Peng). Moving forward, the CEP will be led by Dr. Anil Sood, who is an outstanding role model and most effective mentor.